Overview

Study of AggreGuide A-100 (ADP) Assay

Status:
Completed

Trial end date:
2018-06-01

Target enrollment:

Participant gender:

Summary

Study to evaluate the performance of the AggreGuide A-100 ADP assay for detection of platelet dysfunction caused by P2Y12 inhibitor antiplatelet therapy.

Phase:

N/A

Details

Lead Sponsor:

Aggredyne, Inc.

Treatments:

Clopidogrel
Prasugrel Hydrochloride
Ticagrelor